Indiana’s bone and joint brain trust just scored one of the biggest science bets on the table. An Indiana University-led coalition has been selected for a federal innovation prize that could bring up to $160 million over the next decade to speed new treatments, devices and workforce training for bone and musculoskeletal conditions. Branded IMPACT, the effort will start with federal seed money and is built to move discoveries from university labs into clinics and factory floors across the state. University leaders say the award will supercharge local labs, manufacturers and training programs that already serve patients with arthritis, osteoporosis and fractures.
According to the National Science Foundation, each NSF Regional Innovation Engine receives an initial $15 million over the first two years and may secure up to $160 million over a 10-year implementation period. That tiered structure sets the upper limit for Indiana’s IMPACT coalition and is designed to knit together research, industry and workforce development so regional economies see real returns and new medical technologies get into practice faster.
What IMPACT will pursue
Formally known as the Indiana Musculoskeletal Health Partnership for the Advancement of Care & Treatment, IMPACT plans to zero in on arthritis, osteoporosis and fracture care while speeding up device and drug development. The coalition’s roadmap calls for training more than 1,900 workers, launching more than 85 startups and pushing at least 30 innovations to market, goals that would be built out with support from the NSF Engine award, according to The Indianapolis Star.
How Indiana will build on existing strengths
IMPACT is designed to tie IU researchers to the state’s MedTech Corridor, including manufacturers in Warsaw, along with industry partners that can move prototypes into production and clinical trials. IU officials point to existing efforts such as MSKMobile, a mobile screening and research unit, and MSKTrain, a K-12 through reskilling workforce program. Indiana University President Pamela Whitten argued that “Indiana is unrivaled in the strengths needed to quickly turn musculoskeletal breakthroughs into new technologies, new companies and high-quality jobs,” as outlined by IU News.
Partners and local impact
The IMPACT coalition pulls together more than 100 academic, clinical and industry partners, including Eli Lilly, Zimmer Biomet, the Regenstrief Institute, Purdue University and the University of Notre Dame, to create a pipeline from lab bench to bedside and the factory floor. Project leaders cite Indiana’s manufacturing base and life sciences network as key reasons the state can turn research wins into jobs and startups relatively quickly, per the IMPACT project website at MSK IMPACT.
For now, program leaders say the immediate priorities are setting up governance, choosing initial projects and launching pilot efforts that the early federal dollars will support. Larger, milestone-driven funding would follow if the Engine hits NSF performance targets. Officials expect to roll out specific pilot projects, training timetables and partnership milestones in the coming months as IMPACT moves from planning into execution.
